Defining intermediate-risk non-muscle-invasive bladder cancer

被引：0
|
作者：
S. Bruce Malkowicz
机构：
[1] Perelman School of Medicine,Division of Urology, Department of Surgery
[2] University of Pennsylvania,undefined
来源：
Nature Reviews Urology | 2014年 / 11卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The pathology of intermediate-risk non-muscle-invasive bladder cancer is less well-defined than both high-risk and low-risk presentations of this disease. Recently reported guidelines seek to aid clinicians in classification of intermediate-risk patients, and also provide treatment recommendations for this subgroup.
引用
收藏
页码：430 / 432
页数：2
相关论文
共 50 条
  • [31] Prediction model for recurrence probabilities after intravesical chemotherapy in patients with intermediate-risk non-muscle-invasive bladder cancer, including external validation
    Rianne J. M. Lammers
    Jan C. M. Hendriks
    O. Rodriguez Faba Rodriguez Faba
    Wim P. J. Witjes
    Joan Palou
    J. Alfred Witjes
    World Journal of Urology, 2016, 34 : 173 - 180
  • [32] Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer
    Tan, Wei Shen
    McElree, Ian M.
    Davaro, Facundo
    Steinberg, Ryan L.
    Bree, Kelly
    Navai, Neema
    Dinney, Colin P.
    O'Donnell, Michael A.
    Li, Roger
    Kamat, Ashish M.
    Packiam, Vignesh T.
    EUROPEAN UROLOGY ONCOLOGY, 2023, 6 (05): : 531 - 534
  • [33] Intravesical Therapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis of Disease Recurrence
    Laukhtina, Ekaterina
    Abufaraj, Mohammad
    Al-Ani, Abdallah
    Ali, Mustafa Rami
    Mori, Keiichiro
    Moschini, Marco
    Quhal, Fahad
    Motlagh, Reza Sari
    Pradere, Benjamin
    Schuettfort, Victor M.
    Mostafaei, Hadi
    Katayama, Satoshi
    Grossmann, Nico C.
    Fajkovic, Harun
    Soria, Francesco
    Enikeev, Dmitry
    Shariat, Shahrokh F.
    EUROPEAN UROLOGY FOCUS, 2022, 8 (02): : 447 - 456
  • [34] Landmarks in non-muscle-invasive bladder cancer
    Laura S. Mertens
    Yann Neuzillet
    Simon Horenblas
    Bas W. G. van Rhijn
    Nature Reviews Urology, 2014, 11 : 476 - 480
  • [35] Approaches to Non-Muscle-Invasive Bladder Cancer
    Hannah Slovacek
    Jerry Zhuo
    Jennifer M. Taylor
    Current Oncology Reports, 2021, 23
  • [36] Approaches to Non-Muscle-Invasive Bladder Cancer
    Slovacek, Hannah
    Zhuo, Jerry
    Taylor, Jennifer M.
    CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
  • [37] STRATIFICATION OF INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS: IMPLICATIONS FOR ADJUVANT THERAPIES
    Soria, Francesco
    D'andrea, David
    Gust, Kilian
    Gontero, Paolo
    Shariat, Shahrokh
    ANTICANCER RESEARCH, 2019, 39 (03) : 1593 - 1594
  • [38] IMPACT OF BLADDER NECK INVOLVEMENT AND POSITIVE URINE CYTOLOGY IN SUBSTRATIFYING INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS BASED ON THE PREDICTION OF HIGH-RISK RECURRENCE
    Fukushima, Hiroshi
    Toide, Masahiro
    Fukuda, Shohei
    Moriyama, Shingo
    Yasuda, Yosuke
    Uehara, Sho
    Kijima, Toshiki
    Yoshida, Soichiro
    Yokoyama, Minato
    Ishioka, Junichiro
    Matsuoka, Yoh
    Saito, Kazutaka
    Fujii, Yasuhisa
    JOURNAL OF UROLOGY, 2019, 201 (04): : E626 - E626
  • [39] ADVERSE EVENTS AFTER TRANSURETHRAL RESECTION OF INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Sharma, Vidit
    Aaronson, David S.
    Fero, Katherine E.
    Lec, Patrick M.
    Chamie, Karim
    Lee, Valerie S.
    Quesenberry, Charles
    Munneke, Julie R.
    Schoenberg, Mark
    Kushi, Lawrence H.
    Tang, Li
    Kwan, Marilyn L.
    JOURNAL OF UROLOGY, 2021, 206 : E122 - E122
  • [40] Experimental and New Approaches for Bladder Preservation in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
    Avilez, Natalia
    Capibaribe, Diego M.
    Reis, Leonardo
    RESEARCH AND REPORTS IN UROLOGY, 2024, 16 : 89 - 113
12345